BDBM800464 N-(3-((6-(4H- 1,2,4-triazol-4- yl)-1H-indazol-4- yl)amino)propyl)- 3-((3-cyano-4- cyclobutoxybenzyl) amino)propan-::N-(3-((6-(4H-1,2,4-triazol-4-yl)-1H-indazol-4-yl)amino)propyl)-3-((3-cyano-4-cyclobutoxybenzyl)amino)propan-amide::US20260085062, Example 39

SMILES N#Cc1cc(CNCCC(=O)NCCCNc2cc(-n3cnnc3)cc3[nH]ncc23)ccc1OC1CCC1

InChI Key InChIKey=QYTUWGPHZINMGI-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 800464   

TargetCasein kinase II subunit alpha(Human)
Cambridge Enterprise

US Patent
LigandChemical structure of BindingDB Monomer ID 800464BDBM800464(N-(3-((6-(4H- 1,2,4-triazol-4- yl)-1H-indazol-4- y...)
Affinity DataIC50: 0.280nMAssay Description:Final assay conditions comprised 0.2 nM CK2α, 50 μM peptide substrate (RRRADDSDDDDD), 15 μM ATP in 1× reaction buffer (40 mM Tris pH7.5, 200 mM NaCl,...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent

TargetDual specificity protein kinase CLK2(Human)
Cambridge Enterprise

US Patent
LigandChemical structure of BindingDB Monomer ID 800464BDBM800464(N-(3-((6-(4H- 1,2,4-triazol-4- yl)-1H-indazol-4- y...)
Affinity DataIC50: 63.3nMAssay Description:The assay was conducted in the same way as described for CK2α, with final assay conditions comprising 20 nM CLK2 (Carna Biosciences-04-127), 50 μM pe...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent